Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations.

Autor: Sonmez A; Department of Endocrinology and Metabolism, Gulhane School of Medicine, University of Health Sciences, Ankara, Turkey., Sabbour H; Heart & Vascular Institute Cleveland Clinic, Abu Dhabi, UAE.; Brown University Warren Alpert School of Medicine, Providence, Rhode Island, USA., Echtay A; School of Medicine, Lebanese University, Hadath, Lebanon., Rahmah AM; National Centre for Diabetes, College of Medicine, Al-Mustansriya University, Baghdad, Iraq., Alhozali AM; Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia., Al Sabaan FS; Security Forces Hospital, Riyadh, Saudi Arabia., Haddad FH; Endocrine & Diabetes, Abdali Hospital/Endocrine & Diabetes Clinic, Amman, Jordan., Iraqi H; Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco., Elebrashy I; Faculty of Medicine, Cairo University, Cairo, Egypt., Assaad SN; University of Alexandria, Alexandria, Egypt., Bayat Z; Division of Endocrinology and Metabolism, Department of Internal Medicine, Helen Joseph Hospital, Rossmore, Johannesburg, South Africa., Osar Siva Z; Turkish Diabetes Association, Turkey., Hassanein M; Dubai Hospital, DHA, Dubai, UAE.; Gulf Medical University, Ajman, UAE.; Cardiff University, Cardiff, UK.
Jazyk: angličtina
Zdroj: Journal of diabetes [J Diabetes] 2022 May; Vol. 14 (5), pp. 315-333. Date of Electronic Publication: 2022 Apr 17.
DOI: 10.1111/1753-0407.13266
Abstrakt: The upsurge of type 2 diabetes mellitus is a major public health concern in the Middle East and North Africa (MENA) and Africa (AFR) region, with cardiorenal complications (CRCs) being the predominant cause of premature morbidity and mortality. High prevalence of cardiometabolic risk factors, lack of awareness among patients and physicians, deficient infrastructure, and economic constraints lead to a cascade of CRCs at a significantly earlier age in MENA and AFR. In this review, we present consensus recommendations by experts in MENA and AFR, highlighting region-specific challenges and potential solutions for management of CRCs. Health professionals who understand sociocultural barriers can significantly increase patient awareness and encourage health-seeking behavior through simple educational tools. Increasing physician knowledge on early identification of CRCs and personalized treatment based on risk stratification, alongside optimum glycemic control, can mitigate therapeutic inertia. Early diagnosis of high-risk people with regular and systematic monitoring of cardiorenal parameters, development of region-specific care pathways for timely referral to specialists, followed by guideline-recommended care with novel antidiabetics are imperative. Adherence to guideline-recommended care can catalyze utilization of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists with demonstrated cardiorenal benefits-thus paving the way for overcoming care gaps in a cost-effective manner. Leveraging digital technology like electronic medical records can help generate real-world data and provide insights on voids in adoption of newer antidiabetic medications. A patient-centric approach, collaborative care among physicians from different specialties, alongside involvement of policy makers are key for improving patient outcomes and quality of care in MENA and AFR.
(© 2022 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje